Cervical cancer is the malignancy of cervical cells; it is a kind of cancer which develops in a woman’s cervix, i.e., the entrance of the womb from the vagina. Cervical cancer is caused due to unrestrained division of cancerous and/or abnormal cell growth in the cervix region. This cancer has no prominent symptoms in the early stages; however, in a few rare cases vaginal bleeding occur especially post sexual intercourse. Sexually active women are more prone to cervical cancer and clinically it is determined by vaginal discharge, pelvic pain, vaginal pain during sex and while menstruation. World Health Organization (WHO) stated that cervical cancer is the second most commonly occurring cancer and the third largest cause of death in women. The statistics stated that there are 530,000 new cases of cervical cancer every year. Almost 99% of cervical cancer cases occur owing to Sexually Transmitted Infection (STI) of Human Papillomavirus (HPV infection) from an infected individual. The HPV infection leads to DNA mutation in cervical cells which change the growth of the cell which results into uncontrolled cell growth in and the most common type of cervical cell cancer comprise of Adenocarcinoma and Squamous Cell Malignancy. The most effective detection test of cervical cancer is Pap Smear Test and others include HPV test, Colposcopy, Endocervical curettage and Biopsy. It precancerous cells are detected at an early stage, and appropriate treatment is endorsed, it can help in preventing the progression of the cancer into the cervix.
Top Manufactures Analysis of Cervical Cancer: Pfizer, Teva, Taj Pharmaceuticals, Ifotam, Novartis
To Browse Complete Report, Click Here: http://www.qyresearchgroups.com/report/western-europe-cervical-cancer-market-size-status-and-forecast-2021
The Western Europe Cervical Cancer Market has been estimated to witness considerable growth while growing at a higher CAGR during the forecast period. Increased cases of HIV-infected individuals and inhibited immune system are key market drivers contributing towards the cervical cancer market in Western Europe. Other conducing factors are escalated prevalence of sexual intercourse with an infected person and/or multiple partners, prolonged use of contraceptives and a few genetic conditions, together are fuelling this industry’s market. Nevertheless, in the last decade there has been a substantial growth in preventive market of the European region and several awareness initiatives by the government to knowledge women early diagnostic methods and vaccinations. This majorly assisted in prevention of HPV infection and the deterioration of cervical cancer into advanced states, hence restricting the cervical cancer treatment market. FDA approved vaccines such as Cervarix and Gardasil are easily available and are cost-efficient than the actual treatments, and this has resulted in a pessimistic impact on cervical cancer treatment in this region.
To Request Sample Copy of This Report: http://www.qyresearchgroups.com/request-sample/163198
Based on the diagnostics segment, the market has been segmented into Pap Smear Tests, Colposcopy, and HPV Testing. The cervical cancer treatment market, according to the disease indication has been segmented into Pre-malignant lesions- Cervical Intraepithelial Neoplasia, Early invasive stage, and Advanced invasive stage. The treatment segment of this industry include Cryotherapy, Simple hysterectomy, Cold knife conization, Laser surgery, Cone biopsy, LEEP- Loop electrosurgical excision procedure, Radiation therapy, Chemotherapy, Radical trachelectomy, Hormone therapy, and Targeted therapy. Region-wise, the Western Europe Cervical Cancer Market has been segmented into France, Ireland, Netherlands, Spain, Belgium, and Portugal. Some of the major market players of the Western Europe Cervical Cancer Market are Pfizer, Teva, Taj Pharmaceuticals, Ifotam, and Novartis amongst others.
QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world’s most complete and current database of expert insights on global industries, companies, products, and trends.
Room B1510, ShijiKemao Building, No.66, Zhongguancun East Road,
Haidian District, Beijing, 100190, China